FELIQS is a research-based start-up specializing in pharmaceutical sciences.
FELIQS has raised $8.3M in total funding. The most recent round was Series A. The last funding was announced in July 2025.
FELIQS's investors include Mitsubishi UFJ Capital, Beyond Next Ventures, Keio Innovation Initiative, FFG Venture Business Partners, Japan Science and Technology Agency.
FELIQS is headquartered in Kurume, Japan.
FELIQS is a research-based start-up specializing in pharmaceutical sciences.
FELIQS is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FELIQS — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/feliqs. Accessed October 23, 2026.
VCBacked. (2025). FELIQS — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/feliqs
{{cite web |title=FELIQS — Funding & Investors |url=https://www.vcbacked.co/company/feliqs |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated